首页> 外文会议>Pacific Symposium on Biocomputing >Using simulation and optimization approach to improve outcome through warfarin precision treatment
【24h】

Using simulation and optimization approach to improve outcome through warfarin precision treatment

机译:采用仿真和优化方法通过华法林精密治疗提高结果

获取原文
获取外文期刊封面目录资料

摘要

We apply a treatment simulation and optimization approach to develop decision support guidance for warfarin precision treatment plans. Simulation include the use of~1,500,000 clinical avatars (simulated patients) generated by an integrated data-driven and domain-knowledge based Bayesian Network Modeling approach. Subsequently, we simulate 30-day individual patient response to warfarin treatment of five clinical and genetic treatment plans followed by both individual and subpopulation based optimization. Sub-population optimization (compared to individual optimization) provides a cost effective and realistic means of implementation of a precision-driven treatment plan in practical settings. In this project, we use the property of minimal entropy to minimize overall adverse risks for the largest possible patient sub-populations and we temper the results by considering both transparency and ease of implementation. Finally, we discuss the improved outcome of the precision treatment plan based on the sub-population optimized decision support rules.
机译:我们采用治疗仿真和优化方法,为华法林精密治疗计划制定决策支持指导。仿真包括使用〜1,500,000个临床头像(模拟患者)由集成的数据驱动和域 - 知识的贝叶斯网络建模方法产生。随后,我们模拟了30天的个体患者对华法林治疗五种临床和遗传治疗计划的反应,然后基于个体和亚贫困的优化。子群优化(与个体优化相比)提供了在实际设置中实现精密驱动治疗计划的成本效益和现实的方法。在该项目中,我们使用最小熵的性质,以最大限度地减少最大可能的患者子群体的整体不利风险,并通过考虑透明度和易于实施来调高结果。最后,我们讨论了基于亚群体优化决策支持规则的精密治疗计划的改进结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号